Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase-activated protein kinase 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | map kinase activated protein kinase protein 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Schistosoma mansoni | serine/threonine protein kinase | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Schistosoma japonicum | ko:K04443 mitogen-activated protein kinase-activated protein kinase 2, putative | Get druggable targets OG5_131483 | All targets in OG5_131483 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase-activated protein kinase 2 | 370 aa | 303 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.042 | 0.9919 | 0.9919 |
Brugia malayi | C1-like domain containing protein | 0.0231 | 0.4157 | 0.5469 |
Loa Loa (eye worm) | hypothetical protein | 0.0228 | 0.4065 | 0.4065 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.022 | 0.3827 | 0.3827 |
Echinococcus multilocularis | serine threonine protein kinase | 0.024 | 0.443 | 0.4809 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.017 | 0.231 | 0.1337 |
Brugia malayi | protein kinase C II. | 0.0344 | 0.7601 | 1 |
Echinococcus granulosus | protein kinase C gamma type | 0.024 | 0.443 | 0.4809 |
Onchocerca volvulus | 0.0228 | 0.4065 | 0.431 | |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.032 | 0.6875 | 0.8813 |
Brugia malayi | Phorbol esters/diacylglycerol binding domain | 0.0231 | 0.4157 | 0.5469 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0344 | 0.7601 | 0.7601 |
Echinococcus multilocularis | protein kinase c iota type | 0.0269 | 0.5326 | 0.6276 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0154 | 0.1816 | 0.1816 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.0231 | 0.4157 | 0.4157 |
Onchocerca volvulus | 0.0233 | 0.4216 | 0.4576 | |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.015 | 0.1712 | 0.1712 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.032 | 0.6875 | 0.8813 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0334 | 0.7294 | 0.7294 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.022 | 0.3827 | 0.3822 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.4216 | 0.4216 |
Schistosoma mansoni | protein kinase C mu | 0.0231 | 0.4157 | 0.0873 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.032 | 0.6875 | 0.8078 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Brugia malayi | map kinase activated protein kinase protein 2 | 0.022 | 0.3827 | 0.5036 |
Brugia malayi | protein kinase C3,putative | 0.0183 | 0.2711 | 0.3567 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.162 | 0.162 |
Onchocerca volvulus | 0.0334 | 0.7294 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0334 | 0.7294 | 0.7294 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.022 | 0.3827 | 0.3822 |
Schistosoma mansoni | serine/threonine protein kinase | 0.032 | 0.6875 | 0.8078 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0175 | 0.2461 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.162 | 0.162 |
Trichomonas vaginalis | AGC family protein kinase | 0.0094 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0334 | 0.7294 | 0.7294 |
Loa Loa (eye worm) | hypothetical protein | 0.0143 | 0.1493 | 0.1493 |
Schistosoma mansoni | atypical protein kinase C | 0.0277 | 0.5549 | 0.4562 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0256 | 0.4925 | 0.5618 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0344 | 0.7601 | 1 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0344 | 0.7601 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0269 | 0.5326 | 0.6276 |
Loa Loa (eye worm) | hypothetical protein | 0.042 | 0.9919 | 0.9919 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0344 | 0.7601 | 1 |
Loa Loa (eye worm) | AGC/PKC/IOTA protein kinase | 0.0191 | 0.2934 | 0.2934 |
Brugia malayi | Protein kinase c protein 2 | 0.0234 | 0.4261 | 0.5606 |
Loa Loa (eye worm) | hypothetical protein | 0.0414 | 0.9739 | 0.9739 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.3938 | 0.3938 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 288 nM | Inhibition of MK2 pretreated for 30 mins before fluorescein labeled substrate peptide addition measured after 2 hrs by IMAP assay | ChEMBL. | 21565498 |
EC50 (functional) | = 4.3 uM | Antiinflammatory activity in human PBMC cells assessed as inhibition of LPS-induced TNFalpha production pretreated 30 mins before LPS challenge measured after 4 hrs by ELISA | ChEMBL. | 21565498 |
EC50 (binding) | = 5.8 uM | Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins | ChEMBL. | 21565498 |
EC50 (functional) | = 8.7 uM | Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production pretreated 30 mins before LPS challenge measured after 4 hrs | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of PIM1 at 1 uM | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of PIM3 at 1 uM | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of CHK2 at 1 uM | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of DRAK1 at 1 uM | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of ERK1 at 1 uM | ChEMBL. | 21565498 |
Inhibition (binding) | >= 80 % | Inhibition of ERK2 at 1 uM | ChEMBL. | 21565498 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 21565498 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.